The Dutch Healthcare Inspectorate established last year that there were serious shortcomings at the company. According to the AD there are also investigations into illegal practices. The newspaper reports that the company has around 230,000 customers worldwide.
Due to financial problems, the company moved all stem cell material to Famicord in Poland. In a response to the NOS, that company said that around 65 percent of the inventory had been mapped. Parents who have participated in the stem cell project can report on the website for clarity.
But Nikita says she’s still waiting for an answer. “I want it to be sorted out now so that we can be sure that it is still there and how it should continue.”
“No chance of success”
According to Jan van Lith of the Dutch Association for Obstetrics and Gynecology, Cryo-Save’s customers are misled. He thinks the stem cell material project is far too rosy as something that can help with future disorders.
“It was said: maybe there will be an application in the future. While there is no scientific evidence that this has a chance of success in the long term.”
–
